Safety evaluation of pulmonary influenza vaccination in healthy and "asthmatic" mice

Vaccine

Volumn 26, Issue 19, 2008, Pages 2360-2368

  Minne, Antoine ^a   Huaux, François ^a   Jaworska, Joanna ^b   Rha, Ro Dug ^b   Hamelmann, Eckard ^b   Vanbever, Rita ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Airways; Inflammation; Influenza virus; Mice; Ovalbumin; Pulmonary vaccination; Safety

Indexed keywords

INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; ASTHMA; AVIAN INFLUENZA; BRONCHUS HYPERREACTIVITY; CHRONIC LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; IMMUNOTOXICITY; INFECTION PREVENTION; INFECTION RISK; INFLUENZA VACCINATION; MOUSE; NONHUMAN; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; VIRUS INACTIVATION;

ADMINISTRATION, INHALATION; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; INFLAMMATION; INFLUENZA VACCINES; LEUKOCYTE COUNT; LUNG; MICE; MICE, INBRED BALB C; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, INACTIVATED;

EID: 42649090103     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.02.062     Document Type: Article

References (32)

1. Glezen W.P. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 4 (1982) 25-44
2. Nichol K.L., and Treanor J.J. Vaccines for seasonal and pandemic influenza. J Infect Dis 194 November 1 (Suppl. 2) (2006) S111-S118
3. Belshe R., Lee M.S., Walker R.E., Stoddard J., and Mendelman P.M. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert Rev Vaccines 3 December (6) (2004) 643-654
4. Treanor J., Nolan C., O'Brien D., Burt D., Lowell G., Linden J., et al. Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects. Vaccine 24 January 16 (3) (2006) 254-262
5. Fernandez-de C.J., Kumate-Rodriguez J., Sepulveda J., Ramirez-Isunza J.M., and Valdespino-Gomez J.L. Measles vaccination by the aerosol method in Mexico. Salud Publica Mex 39 January (1) (1997) 53-60
6. Bennett J.V., Fernandez de Castro J., Valdespino-Gomez J.L., Garcia-Garcia Mde L., Islas-Romero R., Echaniz-Aviles G., et al. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bull World Health Organ 80 10 (2002) 806-812
7. Jordan R., Connock M., Albon E., Fry-Smith A., Olowokure B., Hawker J., et al. Universal vaccination of children against influenza: are there indirect benefits to the community?: a systematic review of the evidence. Vaccine 24 February 20 (8) (2006) 1047-1062
8. Weycker D., Edelsberg J., Halloran M.E., Longini I.M., Nizam A., Ciuryla V., et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 23 January 26 (10) (2005) 1284-1293
9. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., and Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344 March 22 (12) (2001) 889-896
10. Ashkenazi S., Vertruyen A., Arístegui J., Esposito S., McKeith D.D., Klemola T., et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 25 October (10) (2006) 870-879
11. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 356 February 15 (7) (2007) 685-696
12. Smith D.J., Bot S., Dellamary L., and Bot A. Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus. Vaccine 21 June 20 (21-22) (2003) 2805-2812
13. Minne A., Louahed J., Mehauden S., Baras B., Renauld J.C., and Vanbever R. The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response. Immunology (May 2007) 22
14. Fleming D.M., Crovari P., Wahn U., Klemola T., Schlesinger Y., Langussis A., et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 25 October (10) (2006) 860-869
15. Hamelmann E., Oshiba A., Loader J., Larsen G.L., Gleich G., Lee J., et al. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Respir Crit Care Med 155 March (3) (1997) 819-825
16. Hamelmann E., Schwarze J., Takeda K., Oshiba A., Larsen G.L., Irvin C.G., et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156 September (3 Pt 1) (1997) 766-775
17. Schwarze J., Hamelmann E., Cieslewicz G., Tomkinson A., Joetham A., Bradley K., et al. Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice. J Allergy Clin Immunol 102 July (1) (1998) 86-93
18. Lasfargues G., Lison D., Maldague P., and Lauwerys R. Comparative study of the acute lung toxicity of pure cobalt powder and cobalt-tungsten carbide mixture in rat. Toxicol Appl Pharmacol 112 January (1) (1992) 41-50
19. Sacca R., Cuff C.A., and Ruddle N.H. Mediators of inflammation. Curr Opin Immunol 9 December (6) (1997) 851-857
20. Hubbard R.C., Fells G., Gadek J., Pacholok S., Humes J., and Crystal R.G. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest 88 September (3) (1991) 891-897
21. Tetley T.D. Macrophages and the pathogenesis of COPD. Chest 121 Suppl. 5 (May 2002) S156-S159
22. Noguera A., Batle S., Miralles C., Iglesias J., Busquets X., MacNee W., et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 56 June (6) (2001) 432-437
23. Gompertz S., O'Brien C., Bayley D.L., Hill S.L., and Stockley R.A. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 17 June (6) (2001) 1112-1119
24. Schatz M., Patterson R., and Fink J. Immunopathogenesis of hypersensitivity pneumonitis. J Allergy Clin Immunol 60 July (1) (1977) 27-37
25. Larsen G.L., and Holt P.G. The concept of airway inflammation. Am J Respir Crit Care Med 162 August 1 (2) (2000) 2S-6S
26. Quint J.K., and Wedzicha J.A. The neutrophil in chronic obstructive pulmonary disease. J Allergy Clin Immunol 119 May (5) (2007) 1065-1071
27. Taube C., Dakhama A., and Gelfand E.W. Insights into the pathogenesis of asthma utilizing murine models. Int Arch Allergy Immunol 135 October (2) (2004) 173-186
28. Minne A., Jaworska J., Gerhold K., Ahrens B., Avagyan A., Vanbever R., et al. Intranasal delivery of whole influenza vaccine prevents subsequent allergen-induced sensitization and airway hyper-reactivity in mice. Clin Exp Allergy 37 August (8) (2007) 1250-1258
29. Tulic M.K., Wale J.L., Holt P.G., and Sly P.D. Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 22 May (5) (2000) 604-612
30. Gerhold K., Blümchen K., Bock A., Seib C., Stock P., Kallinich T., et al. Endotoxins prevent murine IgE production, T (H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol 110 July (1) (2002) 110-116
31. Gerhold K., Bluemchen K., Franke A., Stock P., and Hamelmann E. Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice. J Allergy Clin Immunol 112 August (2) (2003) 389-396
32. Gerhold K., Avagyan A., Seib C., Frei R., Steinle J., Ahrens B., et al. Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice. J Allergy Clin Immunol 118 September (3) (2006) 666-673